(Q42537158)

1 November 2017

PD 176252--the first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonist (English)

1 reference

1 November 2017

Ashwood V

1

1 reference

1 November 2017

Brownhill V

2

1 reference

1 November 2017

Higginbottom M

3

1 reference

1 November 2017

Horwell DC

4

1 reference

1 November 2017

Hughes J

5

1 reference

1 November 2017

Lewthwaite RA

6

1 reference

1 November 2017

McKnight AT

7

1 reference

1 November 2017

Pinnock RD

8

1 reference

1 November 2017

Pritchard MC

9

1 reference

1 November 2017

Suman-Chauhan N

10

1 reference

1 November 2017

Webb C

11

1 reference

1 November 2017

Williams SC

12

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

Bioorganic & Medicinal Chemistry Letters

1 November 2017

1 reference

1 November 2017

8

1 reference

1 November 2017

18

1 reference

1 November 2017

2589-2594

1 reference

The 'peptoid' approach to the design of non-peptide, small molecule agonists and antagonists of neuropeptides

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900462-4

7 January 2021

Rational design of high affinity tachykinin NK2 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900462-4

7 January 2021

Rationally designed "dipeptoid" analogues of CCK. alpha-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900462-4

7 January 2021

The asymmetric synthesis of non-peptide CCK-A receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900462-4

7 January 2021

Two distinct receptor subtypes for mammalian bombesin-like peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900462-4

7 January 2021

Are bombesin-like peptides involved in the mediation of stress response?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900462-4

7 January 2021

Molecular cloning of a new bombesin receptor subtype expressed in uterus during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900462-4

7 January 2021

Progress in the development of potent bombesin receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900462-4

7 January 2021

Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900462-4

7 January 2021

Non-peptide bombesin receptor antagonists, kuwanon G and H, isolated from mulberry

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900462-4

7 January 2021

Utilization of operational schemes for analog synthesis in drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900462-4

7 January 2021

Structure-activity requirements of bombesin for gastrin-releasing peptide- and neuromedin B-preferring bombesin receptors in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900462-4

7 January 2021

10.1016/S0960-894X(98)00462-4

Identifiers

DOI

1 reference

1 November 2017

1 reference